5/17/2012 Donna Summer: #LungCancer Leading Cause of #Cancer Death @bonniejaddario @joegaeta @teamdraftRead NowBy Eryn Brown Orginally publshed by the Los Angeles Times on May 17, 2012, 3:16 p.m. Disco legend Donna Summer, 63, died Wednesday night, reportedly of lung cancer. As of press time, her family hadn’t released details about her illness, so it was unknown what type of lung cancer she had, and how long she may have been ailing. According to the American Cancer Society, lung cancer is the leading cause of cancer death in both women and men, killing more than 150,000 people per year -- more than colon, breast, ovarian and prostate cancers combined. In 2012, the group estimates, there will be about 226,000 new cases of lung cancer in the U.S. Survival rates of people with lung cancer are low. Only about half of people diagnosed with early-stage non-small-cell lung cancer (the more common type) survive five years or more after diagnosis; many lung cancer cases aren't discovered until late in the disease's progression, however, because symptoms often don't arise until the disease is advanced. The risk of developing lung cancer increases with age, but it’s not unheard of for relatively young people to die from the disease. Joe Paterno died of lung cancer at 85; Peter Jennings at 67; Christopher Reeve's widow, Dana, at 44. According to some news reports, Summer hoped to keep her medical condition under wraps. The reasons why are unknown -- but according to Rachel Schwartz, a spokeswoman for the Lung Cancer Foundation of America, it’s not unusual for people with lung cancer to feel ashamed of having the disease, because it is so closely associated with a negative behavior: smoking. "Many famous people who have lung cancer never disclose this fact, which speaks to the huge stigma of this disease," Schwartz wrote in an email. "The stigma of the disease is crushing and any announcement of a lung cancer diagnosis is often accompanied by an assumption that you somehow brought the disease upon yourself." Smoking is the leading risk factor for lung cancer, causing about 90% of the cases, according to the U.S. Centers for Disease Control and Prevention. But about 60% of new lung cancer patients either never smoked or haven’t smoked for many years, Schwartz said. Reeve was a non-smoker; Jennings a 20-year former smoker who admitted to relapses here and there. Second-hand smoke is a known carcinogen. A Web search did not reveal if Summer smoked. News outlets reported Thursday that she believed she developed lung cancer after breathing in dangerous particles in the air in the aftermath of New York's Sept. 11 attacks. Copyright © 2012, Los Angeles Times
1 Comment
5/9/2012 Woman w/ #lungcancer aims to end #stigma associated w/ the disease by getting on @TheEllenShowRead NowThis article was originally published on www.ksby.com on May 9th, 2012. by Carina Corral A Lompoc resident has terminal lung cancer, even though she never smoked a day in her life. Now, Mary Anne Rios now aims to end the stigma associated with lung cancer and her mission involves Ellen DeGeneres. She has a lot of fond memories of her family, friends and years as a counselor at Lompoc High School. She would like one of her last to be of dancing on the Ellen Show. "I can't find anybody to support lung cancer because there's such a stigma on it.. She's so tolerant and accepting of so many people that maybe she would do this." An on-line petition has been started to get Mary Anne on the Ellen Show. In just a short time, it has collected thousands of signatures. "I just don't want anyone else to go what I went through, misdiagnosed, because my story is not unique." Mary Anne is not a smoker and no one in her family is, so she said doctors never thought her chronic cough, hoarseness, and a lump in the back of her neck could be lung cancer. They were wrong. "The biggest problem with lung cancer is that it's the least funded and the number one killer.. I've had to tell so many medical personnel about the symptoms of lung cancer and I shouldn't be the ones telling them they should be telling me." It went untreated for so long, it spread to her brain and spine. Doctors don't give her much longer to live. "I call it my bucket wish list because of the movie The Bucket List." Mary Anne has checked many things off her list that include meeting Kurt Russell and going to Disneyland with her family. "I want to ride in a limo bus, a dancing one with my friends, and I want to make it to my birthday and dance with my husband," Mary Anne said of the items on her list that remain unchecked. Dancing with Ellen also tops the list. She wants it to be a fun way to spread her important message, "that anyone with lungs can get lung cancer." Mary Anne is trying to raise money and awareness for lung cancer research. On her own, she has already raised $20,000 by organizing walks and vigils in Lompoc. Click here to sign the online petition to get Mary Anne on the Ellen Degeneres show. © 2012 KSBY.com 4/10/2012 @TheHankBaskett Holds Super Bowl of Golf Tournaments May 20-21 to Score Financial Backing for the Bonnie J. Addario Lung Cancer Foundation #lungcancer @hbgolfclassicRead NowHank Baskett and his Dad. SAN FRANCISCO, April 10, 2012 /PRNewswire-USNewswire/ -- NFL wide receiver Hank Baskett, former Minnesota Vikings player, is calling on his A-Team list of players and celebrities to drive Lung Cancer off the earth and score major funding for the Bonnie J. Addario Lung Cancer Foundation with an inaugural charity golf tournament May 21 at Donald Trump's golf club in Rancho Palos Verdes in California. Baskett has recruited a major league team of power hitters to attend including: Kendra Wilkinson, Stephen C. Bishop, Christopher Duncan, Alfonso Ribeiro, Jermaine Dye, Michael Strahan, Corey Dillon, Jessica Hall, Sara Underwood, Jayde Nicole, Tosh Berman, David Justice, Marcellus Wiley, Danielle Fishel, Matt Nordgren, Kris Humphries, Kevin Love, Danny Granger, Adrienne Maloof and Eric Allen. The celebrated football player is determined to smash this deadly opponent – Lung Cancer. The statistics are grim: 1.6 million people worldwide will be diagnosed with Lung Cancer this year. Only 15.5% will survive. He's teaming up with the foundation because he's determined to help us make a powerful impact and a winning difference. The Bonnie J. Addario Lung Cancer Foundation has raised $9 million to support research and related patient services, and has become a recognized global leader in Lung Cancer research. It provides patient empowerment, support, referrals, and valuable information on up-to-the-minute treatment options, genetic testing and personalized medicine, offering hope that Lung Cancer can become a chronically managed disease in our lifetime. "We're proud to be partnering with Hank Baskett," says Bonnie J. Addario, founder and a Lung Cancer survivor. "We're so honored to have Hank on our team helping to raise essential funding and awareness for Lung Cancer and the message that ANYONE CAN GET LUNG CANCER." Baskett also will serve as honorary chair of the Seventh Annual Golf Tournament on June 11, 2012 at Green Hills Country Club in Millbrae, CA. Addario urges everyone: "To join the efforts in changing the inexcusable 15.5 percent survival rate for Lung Cancer patients and to help and support the foundation in saving lives and supporting our efforts." Ninety percent of all funds raised support research and mission related programming. The invitation-only VIP Welcome Reception will be held at 7 p.m. in the Catalina Ballroom of the Terranea Resort and Spa in Rancho Palos Verdes, overlooking the Pacific Ocean. Registration begins at 10 a.m. on May 21, the next day, for The Hank Baskett Classic Golf Tournament followed by lunch and a shotgun start at 11:30 a.m. at Trump National Golf Club. Sponsorship packages are available through The Griffin Gives Foundation for tee box sponsors (prices vary according to the level of sponsorship). To inquire about sponsorship opportunities please click HERE or contact tracey@giffingives.org or at 267-382-0261. For more information, contact Sheila Von Driska, Communications, at 415.357.1278 or sheila@lungcancerfoundation.org. About the Bonnie J. Addario Lung Cancer Foundation BJALCF is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. BJALCF was established on March 6, 2006 as a 501© (3) non-profit organization. Photo courtesy of Hank Baskett SOURCE: Bonnie J. Addario Lung Cancer Foundation 4/5/2012 #LungCancer vanity plate makes swift move through GA General Assembly @bonniejaddario @jackieshope @teamdraftRead NowThis article was originally published in the Cherokee Ledger-News on 4/3/12. By: Jessica Wagner (PHOTO INSERT: Rep. Sean Jerguson, R-Holly Springs, and former Holly Springs Councilwoman Jacqueline Archer stand with a sample lung cancer awareness vanity plate. The plates should be on the back of vehicles by this summer. Photo special to the Ledger-News) In less than two months, former Holly Springs City Councilwoman Jacqueline Archer has accomplished something that takes many people a year, if not years, to achieve. A bill calling for the production of a lung cancer awareness vanity plate passed both houses March 26 and has made its way to Gov. Nathan Deal’s office; the bill had not been signed by press time. “I am just so excited,” said Archer. “I had no doubt that it was going to go through, but I had no idea that the other license plates, according to Rep. Sean Jerguson, have taken a year or more.” Archer, 47, called the bill a victory for anyone who has been or will be affected by lung cancer in the state. “It all started in Cherokee County because that’s where I am from, but if we could start it here and continue on, then that’s where I would like to go,” she said. “I am thinking big.” Twelve additional states, including California, Illinois, Oklahoma, North Carolina, Florida, New Jersey and Maine, have pledged to follow in Georgia’s footsteps with a vanity plate that will mirror Archer’s mission of spreading lung cancer awareness. “What I am working on right now is an example of what Georgia’s process was for getting the license plate through all of the hoops, understanding that other states may have nuances that are particular to that state,” Archer said. As a stage III never-smoking lung cancer survivor, Archer said spearheading the specialized license plate has been a dream of hers since she overcame her battle with the disease in August of 2005, just 12 weeks after being diagnosed. Her diagnosis came as a surprise six years ago when Archer was involved in a car accident. At the hospital, doctors found an orange-sized mass, which, along with 31 lymph nodes, was successfully removed. Her survival sparked a mission to spread awareness about a disease that she called “underfunded.” The pieces began falling together this past January after Archer teamed up with Jerguson and The Joan Gaeta Lung Cancer Fund to make her vision a reality. The state required 1,000 pre-order commitments prior to legislators casting a vote. While the vanity plates met the requirements set forth by the state, residents interested in donning the lung cancer awareness plate on the back of their vehicles can still place orders at www.lungcancerlicenseplate.org. “We are supplying to the Department of Driver Services everyone who is pre-paying for the license plate, along with the county that the resident lives in and their driver’s license number,” Archer said. By this summer, residents who placed pre-paid orders, as well as first-time payers, can pick up their plates. The money collected from the vanity plate sales are pre-designated for the Addario Lung Cancer Medical Institute (ALCMI) through the listed recipient, The Joan Gaeta Lung Cancer Fund. “Now, we are going to be able to see a financial impact on research and early detection so that we can reach the goal by 2020 of having a survival rate of 50 percent versus the 15 percent that has remained unchanged for the last 40 years,” Archer said. In addition to taking lung cancer awareness vanity plates from coast-to-coast, Archer is traveling to Washington D.C. for a Congressional event April 19. During the event she will speak to legislators about unmasking lung cancer on purpose and not by chance, as was her story. “I am going to testify on behalf of early detection,” she said, adding it is a collaborative event with herself and Dr. Henry Krebs, director of interventional radiology at St. Joseph’s Hospital. “He will be speaking to the medical side of lung cancer; I will be speaking to the lack of early detection screening and my story.” Archer has also reached out to Cherokee County Tax Commissioner Sonya Little to promote the lung cancer awareness vanity plates during National Lung Cancer Awareness Month every November. Danielle Hicks, Director of Patient Advocacy and Empowerment at the Bonnie J. Addario Lung Cancer Foundation shares the BJALCF story and mission with Comcast Newsmakers and upcoming information on the June 11, 2012 Golf Tournament and Simply the Best Dinner Gala VII on November 10, 2012 in San Francisco.
3/23/2012 The Joan Gaeta #LungCancer Fund Commits $30,000 to the Addario Lung Cancer Medical InstituteRead Now Atlanta, GA (PRWEB) March 23, 2012 - For the fifth consecutive year, The Joan Gaeta Lung Cancer Fund's annual “Dancing for Joan” event was a huge success and served as the climax to their most successful year of fundraising. Today, the Gaeta Fund announced their commitment of $30,000 to international lung cancer research through the Addario Lung Cancer Medical Institute (ALMCI). They also announced the commitment of $6,000 to local awareness initiatives in 2012. On Saturday, February 25th, nearly 200 supporters gathered together at the Pavilion of East Cobb in Marietta, Georgia for the fifth annual lung cancer fundraiser. They were treated to great food, great music, and - of course - dancing. Guests were also educated and inspired by an impressive lineup of speakers. Leading things off after the cocktail hour was the Honorary Chairman of the event, Dr. Paul Scheinberg, Chief of Medical Staff at Saint Joseph's Hospital in Atlanta, Founder of Atlanta Pulmonary Group, and tireless lung cancer advocate. He explained the changes in the profile of the "typical" lung cancer patient over the last 20 years and urged people to fight the stigma. Next, guests welcomed former NFL linebacker Chris Draft, who recently lost his wife to lung cancer a mere month after they were married. They viewed his profile from ESPN and heard his inspiring words as he honors the memory of his beautiful wife Keasha with the launch of "Team Draft". We then heard from Bonnie Addario, Founder and President of the Bonnie J. Addario Lung Cancer Foundation and the Addario Lung Cancer Medical Institute (ALCMI). The cornerstone presentation of the evening recapped the advances these organizations have made in the fight against lung cancer. In July of 2010, the Gaetas announced their formal partnership with ALCMI, committing 85 percent of their net proceeds to the excellent work they are doing. Remaining funds are used in metro Atlanta for annual awareness initiatives. The “Dancing for Joan” presenting sponsor was represented by Patti Owen, Director of Oncology Services at Northside Hospital in Atlanta. She gave an update of the exciting things that are taking shape at Northside regarding the treatment of cancer - in particular lung cancer. “We are very excited about our partnership with ALMCI and for what our annual event was able to accomplish,” says Joe Gaeta, president of The Joan Gaeta Lung Cancer Fund, and son of the late Joan Gaeta, in whose memory the organization was founded. “We are confident that our supporter’s generous donations will make a deep and immediate impact with ALCMI.” “We are incredibly and deeply thankful to the Gaeta Family for their commitment to ending lung cancer in Joan's memory,” says Bonnie J. Addario, founder. “It is with partners like the Gaeta Fund that will allow ALCMI to begin to raise the 'curability' of lung cancer in a significant way.” A lifelong non-smoker, Joan Gaeta was a devoted wife, teacher, and mother of five. Diagnosed with Lung Cancer in early 2004, she fought a three and a half year battle before succumbing in July of 2007. During that time, Joan stressed the need for greater awareness of Lung Cancer, the number one cancer killer in the world, which has a very low survival rate and a tragic lack of research funds. She was most passionate about eliminating the stigma of the disease, since lung cancer also strikes non-smokers at a high rate. # # # The Joan Gaeta Lung Cancer Fund was created in the fall of 2007 as The Joan Gaeta Lung Cancer Foundation by her husband and children to raise awareness of the disease, to educate the public, and to be an advocate for research. We also strive to eliminate the stigma of lung cancer and to support survivors and their loved ones in our local community. In July of 2010, they re-launched as The Joan Gaeta Lung Cancer Fund benefiting the Addario Lung Cancer Medical Institute. Their ultimate goal remains the same: “to eradicate lung cancer.” By partnering with one significant research initiative, they can make a much greater impact in wiping out lung cancer. ABOUT THE ADDARIO LUNG CANCER MEDICAL INSTITUTE (ALCMI) ALCMI was established in 2008 as a 501(c) (3) non-profit organization with the ultimate goal of significantly impacting survival by directly catalyzing and accelerating discovery of new and more effective treatment options for all lung cancer patients. Presently, ALCMI has 13 academic and community medical centers in the United States and Europe closely collaborating on cutting edge research initiatives. 3/15/2012 #lungcancer survivor spearheads awareness with license plate proposal @jackieshope @bonniejaddario @joegaetaRead NowBy: Jessica Wagner. This article was originally published by the Cherokee Ledger-News on March 14th, 2012 From a former Holly Springs councilwoman to philanthropist, Jacqueline Archer has her hands full, but not to the point where she can’t take on a project that could change lung cancer research for the better. Archer, with the backing of Rep. Sean Jerguson, R-Holly Springs, is asking state legislators to approve a specialty license plate that will not only fund lung cancer research but also spread awareness. However, in order for the state to manufacture the vanity plate, Archer said 1,000 pre-paid commitments are required; roughly 300 have signed up so far. “All of the required paperwork and insurances have to be submitted to the Department of Driver Services (DDS), as well as the logo design,” she said. “Once all of that is approved, that message is sent over to Rep. Jerguson, my dear friend. He will then take it to the delegation, present it and they will vote on it.” Archer said she is trying to speak before the Georgia legislators prior to a vote being cast. As the driving force behind a vanity plate, Archer said she was passionate about the initiative due to her own survival story. Six years ago, Archer was involved in an accident that required transportation to an area hospital for further evaluation. It was then the mother of three learned that she had been battling Adenocarcinoma, the fastest spreading lung cancer. The mass was described as being the size of the doctor’s fist. Now at 47, Archer called the car accident a blessing in disguise because the doctors were able to remove the orange-sized, stage III lung cancer before it spread to her brain, which would have lessened her chance for survival. Thirty-one lymph nodes also were removed from her body. Twelve weeks later, she beat the odds. Archer’s story took an interesting twist when she told the Ledger-News that she was a lifelong nonsmoker who overcame a disease that kills more than 400 people a day, many of whom have never lifted a cigarette to their mouths. Archer said she was determined to pinpoint the reason why nonsmokers develop lung cancer. “There is nothing done for lung cancer; nobody knows why people get it,” she said. Figures from the Lung Cancer Foundation illustrate the lack of understanding, as the survival rate has risen a mere .2 percent between 1971 and 2010 (15.5 percent to 15.7 percent), while the breast cancer survival rate has more than doubled.
Colon and prostate cancer survival rates also have risen from 25.3 percent to 64.8 percent and 21 percent to 99.9 percent, respectively. Archer said when she realized how much this disease is underfunded and how little research has been done, the license plate initiative began. The money collected from the vanity plate sales are pre-designated for the Addario Lung Cancer Medical Institute (ALCMI) through the listed recipient The Joan Gaeta Lung Cancer Fund. “Joan Gaeta died of never-smoking lung cancer. I met Joan 11 weeks after my surgery, and she died the following year,” Archer said. “Her family started a foundation and an annual fundraiser, and I personally chose to align myself with Joan and her family because we have a lot in common.” Archer said she supports ALCMI, as the organization is on the cutting edge of research and development. “From what I found out, there are some organizations that are devoted to patient advocacy and awareness, while there are others that are devoted toward research, prevention, early detection and establishing protocol,” she said. While Archer said she thinks advocacy is good, she wants to back it up and find out how to prevent this disease. “Working with some of the hospitals nearby, we need to establish some kind of standardization of care so that when someone presents with lung cancer that molecular testing is done because it is not being offered right now,” she said. Archer said not enough is being done for a disease where time is a factor. “It spreads quickly; lung cancer patients do not have the luxury of time,” she said. “They have to stop everything … they have to have urgent care and they need to have it from the multi-disciplinary approach, which includes the radiologist, the oncologist, the dietician, the surgeon, etc.” Until a difference is made and a standardization of care is in place, Archer said lung cancer would continue to claim hundreds of lives daily. Pre-paid lung cancer vanity plates, which cost $25, can be ordered through www.lungcancerlicenseplate.org. Additional fees implemented from the DDS might apply. Those interesting in pre-paying for the plate need to provide the county they reside and their driver’s license number. Pre-paid plates can be obtained at the DDS by this summer. We know there's a stigma attached to lung cancer. The first words anyone speaks to someone with lung cancer often makes that too clear. "How long did you smoke?" Can you imagine asking someone with breast cancer how long they were sedentary, or how long they ate a high fat diet? I hope not. That would be depressing...
Knowing that depression is common in people with lung cancer1, and depression occurs more frequently than it does in people with other forms of cancer, researchers set out to see if the stigma of lung cancer might play a role. Their answer was what they expected. There was a significant link between the stigma associated with lung cancer, and depression. Knowing this, they recommend further research designed to see if eliminating the stigma could subsequently reduce the incidence of depression of people living with lung cancer. But even if that's not the case -- even if reducing the stigma doesn't reduce depression - the stigma of lung cancer needs to be stamped out. Nobody deserves lung cancer. Facts www.NobodyDeservesIt.com Headlines www.LungCancerHeadlines.com Georgia License Plate Pre-Order www.LungCancerLicensePlate.org The following story was originally published in the San Francisco Chronicle on January 26th, 2012 by Victoria Colliver, Chronicle Staff Writer. SAN FRANCISCO -- In a finding that could improve the survival odds for early-stage lung cancer patients, UCSF researchers determined a new molecular test can predict more accurately than current diagnostic methods which tumors are more likely to be aggressive and turn deadly. The study results, published today in the medical journal The Lancet, come from the two largest clinical trials ever conducted on the molecular genetics of lung cancer and included early-stage patients from Northern California Kaiser hospitals as well as from China. In both trial groups, a 14-gene test, which was based on developments originally made at UCSF but created by a Mountain View company, was able to accurately determine a patient's odds of death within five years of surgery by analyzing the biological makeup of the tumor. This potentially could save lives by helping patients with early-stage but "bad" disease decide after surgery to remove tumors whether to undergo additional treatment such as chemotherapy or targeted radiation, the researchers said. Jablons Dr. David Jablons, chief of UCSF's thoracic oncology program and an author of the study, called the results a breakthrough for earlier-stage patients who have tough treatment decisions to make. "It can help enhance the chance of curing more patients and this is not an insignificant problem," he said. "This is 50,000 patients in the U.S. alone or more a year and hundreds of thousands of patients a year worldwide." Most deadly cancer Lung cancer is the most common cause of cancer death in the United States as well as the world. More people die each year from lung cancer - some 160,000 people in this country alone - than from breast, colon and prostate cancers combined. One reason it's so deadly is that lung cancer is caught in the early stages in only about 30 percent of those who are diagnosed. Also, unlike other types of cancer where early diagnosis can increase survival upwards of 90 percent, as high as 45 percent of people with the earliest stage of lung cancer die within five years, despite seemingly successful surgery. "The fact of the matter is people do not do well in general, even with early-stage lung cancer," said Jablons. He said current methods of detecting and staging the disease - using scans, surgery and clinical observation - are insufficient to determine the aggressive nature of the disease. The molecular assay, developed by Mountain View's Pinpoint Genomics, analyzes the activity level of the 14 genes in preserved tissue samples as compared to levels in the normal lung. It then characterizes whether that tumor poses a high, intermediate or low risk of death for the patient. This study - which was based on tissue samples from 433 Northern California Kaiser patients and 1,006 patients from China - and found that the test very accurately predicted the likelihood of death in both groups. "There really hasn't been a tool to more clearly identify the patients who have the more difficult biology," said David Berryman, Pinpoint's chief executive officer. "The key to it is to really hone in on a specific set of genes that would be a prognosticator of progression or more aggressive disease." Ready for market Berryman said the test, which received the proper approvals last year, is commercially available but the company has been waiting until these results before moving forward with it. He said he hopes Medicare and health insurers will cover the test as those payers have with other gene-based tests. Health experts say the test is most similar to the diagnostic test Oncotype DX, which can identify the high-risk breast cancer patients who will benefit most from chemotherapy. But what the research involving the Pinpoint test doesn't yet show is whether additional therapy following surgery for lung-cancer patients actually improves survival rates for those patients. "Knowing this result will have benefit (to the patient) is the real question of course," said Stephen Van Den Eeden, research scientist at the Kaiser Permanente's Division of Research in Oakland. Additional research is also needed to identify which chemotherapies would be most beneficial, although genetic testing to identify certain mutations that respond to specific lung cancer therapies is already available. While the studies were funded by Pinpoint and private endowments to UCSF, researchers stressed that they were conducted under strict guidelines and using blinded conditions to prevent bias. Addario Bonnie Addario, a lung cancer survivor and founder of the Bonnie J. Addario Lung Cancer Foundation in San Carlos, called the research "fabulous news" that she expects will lead to better, more targeted therapies for patients in the advent of personalized medicine. "Just a few short years ago, deciding what chemotherapy to give a patient was like throwing spaghetti at the wall," Addario said. "Now we have a much better idea which regimens to put patients on. We're at the tip of the iceberg, but it's moving fast and very exciting." Lung Cancer Statistics An estimated 226,160 new cases of lung cancer will be diagnosed this year in the United States and about 160,340 people will die of the disease. About a third of those are diagnosed in the early stages. Nearly 7 percent of people born today will be diagnosed with lung cancer during their lifetime. Lung cancer claims an estimated 1.4 million lives worldwide every year. $10.3 billion is spent in the United States each year on lung cancer treatment. The National Cancer Institute, the nation's principal agency for cancer research, invested $281.9 million in lung cancer research in 2010. That same year, it invested $300.5 million in prostate cancer and $631.2 million in breast cancer research. Sources: National Cancer Institute; World Health Organization. E-mail Victoria Colliver at vcolliver@sfchronicle.com |
Details
|